MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
13.77
+0.63 (4.79%)
Sep 4, 2026, 4:00 PM EDT - Market closed
MapLight Therapeutics Employees
MapLight Therapeutics had 133 employees as of December 31, 2025. The number of employees increased by 70 or 111.11% compared to the previous year.
Employees
133
Change
70
Growth
111.11%
Revenue / Employee
n/a
Profits / Employee
-$1,728,023
Market Cap
765.28M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 133 | 30 | 29.13% |
| Sep 30, 2025 | 114 | - | - |
| Jun 30, 2025 | 109 | 35 | 47.30% |
| Mar 31, 2025 | 103 | 29 | 39.19% |
| Mar 31, 2024 | 74 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pharming Group | 407 |
| Phathom Pharmaceuticals | 371 |
| Neurogene | 131 |
| DBV Technologies | 126 |
| Aura Biosciences | 113 |
| Verastem | 102 |
| Assembly Biosciences | 73 |
| AgomAb Therapeutics NV | 62 |
MPLT News
- 7 days ago - MapLight Therapeutics price target lowered to $43 from $45 at Needham - TheFly
- 21 days ago - MapLight Therapeutics announces $150M private placement - TheFly
- 22 days ago - MapLight Therapeutics reports Q2 EPS ($1.32), consensus ($1.31) - TheFly
- 22 days ago - MapLight Therapeutics price target lowered to $31 from $35 at Raymond James - TheFly
- 22 days ago - MapLight Therapeutics price target lowered to $21 from $24 at Canaccord - TheFly
- 25 days ago - MapLight Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 25 days ago - MapLight Therapeutics Announces $150 Million Private Placement Financing - GlobeNewsWire
- 25 days ago - MapLight Therapeutics Quarterly report: Q2 2026 - Filings